Lornoxicam Tablets 4 mg, 8 mg Suppliers & Bulk Manufacturers
Available Forms: Oral Tablets
Available Strengths: 4 mg, 8 mg
Reference Brands: Xefo (EU)
Category: Analgesic
Lornoxicam inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing prostaglandin synthesis responsible for pain and inflammation. Benefits include rapid, effective relief from acute pain, inflammation, and rheumatologic conditions. It offers anti-inflammatory, analgesic effects with a favorable safety profile when used appropriately.
Product Description:
Lornoxicam tablets are approved in the EU for managing pain and inflammation, regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, lornoxicam is not approved and is not marketed. In the EU, brands like Xefo (by Orion) are supported by comprehensive clinical data, with ongoing pharmacovigilance. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for lornoxicam tablets, ensuring adherence to European standards for safe, effective pain management, helping you navigate complex regulatory pathways seamlessly.
Lornoxicam Tablets — third party manufacturing & bulk supply
Lornoxicam Tablets 4 mg, 8 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Lornoxicam Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lornoxicam Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lornoxicam is used to relieve pain, inflammation, and swelling in conditions such as osteoarthritis, rheumatoid arthritis, and postoperative or acute musculoskeletal pain.
Lornoxicam is made from the active ingredient lornoxicam, an oxicam-class non-steroidal anti-inflammatory drug (NSAID), along with standard pharmaceutical excipients based on the manufacturer’s formulation.
Common trade names include Xefo and Lornoxicam (regional branded generics).
Lornoxicam is manufactured by several pharmaceutical companies globally, including manufacturers in the EU, UK, and other regulated markets.
The generic name is lornoxicam.
Well-known brand names include Xefo and various regional branded generics.
It is manufactured in multiple countries worldwide, including regions across Europe, the UK, and other approved global pharmaceutical manufacturing locations.
Related Products
Orphenadrine Citrate
Strength:
100 mg, 60 mg/mL, 30 mg/mL
Form: Tablets / injection
Reference Brands: Norflex (USA), Orphenate (USA)
View Details
Methocarbamol
Strength:
500 mg, 750 mg
Form: Tablet / Injection
Reference Brands: Robaxin (USA/EU), Carbacot (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
